MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -18.14M | -15.86M | -12.34M | -10.16M | |
| Total Depreciation and Amortization | 75.00K | 63.00K | 48.00K | 40.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 632.00K | 505.00K | 1.15M | 605.00K | |
| Change in Net Operating Assets | 2.77M | 2.02M | 434.00K | 1.79M | |
| Cash from Operations | -14.66M | -13.27M | -10.71M | -7.73M | |
| Capital Expenditure | -57.00K | -452.00K | -273.00K | -22.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -100.73M | -7.44M | 15.70M | -18.58M | |
| Cash from Investing | -100.79M | -7.89M | 15.43M | -18.61M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 174.51M | 50.00K | 189.00K | 17.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | 63.50M | -- | -- | 68.51M | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2.20M | -1.81M | -6.00K | -30.00K | |
| Cash from Financing | 235.81M | -1.76M | 183.00K | 68.50M | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 120.36M | -22.92M | 4.90M | 42.17M | |
